BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jun 19, 2006
 |  BC Week In Review  |  Company News  |  Deals

BioSpring, Genzyme, SR Pharma, OctoPlus B.V. deal

SPA's Atugen AG subsidiary partnered with GENZ, BioSpring and OctoPlus to manufacture Atugen's Atu027 siRNA therapeutic for cancer. GENZ will...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >